Mature Neutrophils and a NF-κB-to-IFN Transition Determine the Unifying Disease Recovery Dynamics in COVID-19

Amit Frishberg,Emma Kooistra,Melanie Nuesch-Germano,Tal Pecht,Neta Milman,Nico Reusch,Stefanie Warnat-Herresthal,Niklas Bruse,Kristian Haendler,Heidi Theis,Michael Kraut,Esther van Rijssen,Bram van Cranenbroek,Hans JPM. Koenen,Hidde Heesakkers,Mark van den Boogaard,Marieke Zegers,Peter Pickkers,Matthias Becker,Anna C. Aschenbrenner,Thomas Ulas,Fabian J. Theis,Shai S. Shen-Orr,Joachim L. Schultze,Matthijs Kox

DOI: https://doi.org/10.1016/j.xcrm.2022.100652

IF: 16.988

2022-01-01

Cell Reports Medicine

Abstract:Disease recovery dynamics are often difficult to assess, as patients display heterogeneous recovery courses. To model recovery dynamics, exemplified by severe COVID-19, we apply a computational scheme on longitudinally sampled blood transcriptomes, generating recovery states, which we then link to cellular and molecular mechanisms, presenting a framework for studying the kinetics of recovery compared with non -recovery over time and long-term effects of the disease. Specifically, a decrease in mature neutrophils is the strongest cellular effect during recovery, with direct implications on disease outcome. Furthermore, we present strong indications for global regulatory changes in gene programs, decoupled from cell compositional changes, including an early rise in T cell activation and differentiation, resulting in immune rebalancing between interferon and NF-KB activity and restoration of cell homeostasis. Overall, we present a clinically relevant computational framework for modeling disease recovery, paving the way for future studies of the recovery dynamics in other diseases and tissues.